Exploratory Clinical Study on the Safety and Efficacy of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Myeloid Malignancies
Clinical trial NCT06917105 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06917105
- Sponsor
- Tongji Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2027-04-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.